| Dr Woojin Matthew Yu, MD | |
|
630 W 168th St, Vc14-215, New York, NY 10032-3725 | |
| (212) 305-8533 | |
| Not Available |
| Full Name | Dr Woojin Matthew Yu |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 19 Years |
| Location | 630 W 168th St, New York, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033380209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 246046-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hosp So Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG) dealt with the drug aflibercept. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the Institute now examined whether aflibercept (trade name: Eylea) offers an added benefit over the appropriate comparator therapy in visual impairment due to macular oedema following occlusion of the central retinal vein.
A.D.A.M., Inc., a leading provider of health information and benefits technology solutions announced today that University Health Systems of Eastern Carolina has licensed the A.D.A.M. Multimedia Encyclopedia, Heart Center, and other A.D.A.M. health tools for eight of their hospital websites. The A.D.A.M. health information allows the system to provide more robust online health and wellness information to the counties served by the hospital system, and empowers people within those communities to lead healthier lives.
In this report from the Center for Strategic and International Studies, released ahead of the GAVI Alliance pledging conference, authors Lisa Carty, J. Stephen Morrison, Margaret Reeves, and Amanda Glassman write, "Its many achievements notwithstanding, GAVI still needs a strategic approach in the coming years if it is to deepen its impact, get the maximum returns from its implementing partners, attract expanded donor support, and leverage greater commitments from recipient partner governments".
Plexxikon today announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 in patients with previously untreated metastatic melanoma with the BRAF mutation. Patients treated with PLX4032 had an improved overall survival compared to patients treated with dacarbazine, the current standard of care.
› Verified 1 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG) dealt with the drug aflibercept. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the Institute now examined whether aflibercept (trade name: Eylea) offers an added benefit over the appropriate comparator therapy in visual impairment due to macular oedema following occlusion of the central retinal vein.
A.D.A.M., Inc., a leading provider of health information and benefits technology solutions announced today that University Health Systems of Eastern Carolina has licensed the A.D.A.M. Multimedia Encyclopedia, Heart Center, and other A.D.A.M. health tools for eight of their hospital websites. The A.D.A.M. health information allows the system to provide more robust online health and wellness information to the counties served by the hospital system, and empowers people within those communities to lead healthier lives.
In this report from the Center for Strategic and International Studies, released ahead of the GAVI Alliance pledging conference, authors Lisa Carty, J. Stephen Morrison, Margaret Reeves, and Amanda Glassman write, "Its many achievements notwithstanding, GAVI still needs a strategic approach in the coming years if it is to deepen its impact, get the maximum returns from its implementing partners, attract expanded donor support, and leverage greater commitments from recipient partner governments".
Plexxikon today announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 in patients with previously untreated metastatic melanoma with the BRAF mutation. Patients treated with PLX4032 had an improved overall survival compared to patients treated with dacarbazine, the current standard of care.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Woojin Matthew Yu, MD 630 W 168th St, Vc14-215, New York, NY 10032-3725 Ph: (212) 305-8533 | Dr Woojin Matthew Yu, MD 630 W 168th St, Vc14-215, New York, NY 10032-3725 Ph: (212) 305-8533 |
News Archive
For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG) dealt with the drug aflibercept. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the Institute now examined whether aflibercept (trade name: Eylea) offers an added benefit over the appropriate comparator therapy in visual impairment due to macular oedema following occlusion of the central retinal vein.
A.D.A.M., Inc., a leading provider of health information and benefits technology solutions announced today that University Health Systems of Eastern Carolina has licensed the A.D.A.M. Multimedia Encyclopedia, Heart Center, and other A.D.A.M. health tools for eight of their hospital websites. The A.D.A.M. health information allows the system to provide more robust online health and wellness information to the counties served by the hospital system, and empowers people within those communities to lead healthier lives.
In this report from the Center for Strategic and International Studies, released ahead of the GAVI Alliance pledging conference, authors Lisa Carty, J. Stephen Morrison, Margaret Reeves, and Amanda Glassman write, "Its many achievements notwithstanding, GAVI still needs a strategic approach in the coming years if it is to deepen its impact, get the maximum returns from its implementing partners, attract expanded donor support, and leverage greater commitments from recipient partner governments".
Plexxikon today announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 in patients with previously untreated metastatic melanoma with the BRAF mutation. Patients treated with PLX4032 had an improved overall survival compared to patients treated with dacarbazine, the current standard of care.
› Verified 1 days ago
Dr. Phillip Kaplan, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 325 N End Ave, 10-k, New York, NY 10282 Phone: 212-945-0869 Fax: 212-945-0869 | |
Dr. Iris Teo, Pathology Medicare: Not Enrolled in Medicare Practice Location: 504 E 89th St, New York, NY 10128 Phone: 646-535-5553 | |
Dr. Alexander K Lyashchenko, Pathology Medicare: Not Enrolled in Medicare Practice Location: 8 Magaw Pl Apt 24b, New York, NY 10033 Phone: 917-463-9183 | |
Alexandra Budhai, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1275 York Ave, New York, NY 10065 Phone: 212-639-2000 | |
Dr. Farshad Shafizadeh, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 461 Park Ave S, 5th Floor, New York, NY 10016 Phone: 212-777-8566 Fax: 646-536-8738 | |
Narasimhan P Agaram, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1275 York Ave, New York, NY 10065 Phone: 212-639-2000 | |
Margaret Brandwein-weber, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1000 Tenth Avenue, New York, NY 10019 Phone: 212-523-8641 Fax: 212-523-7232 |